北京康辰药业股份有限公司关于使用部分闲置募集资金进行现金管理赎回的公告

Core Points - The company approved the use of up to RMB 300 million of idle raised funds for cash management, valid for 12 months from the board's approval date [1] - The company has redeemed principal and investment income from previously purchased capital-protected products, returning the funds to the designated account [1]